214 related articles for article (PubMed ID: 16834767)
1. High-throughput genomic technology in research and clinical management of breast cancer. Evolving landscape of genetic epidemiological studies.
Low YL; Wedrén S; Liu J
Breast Cancer Res; 2006; 8(3):209. PubMed ID: 16834767
[TBL] [Abstract][Full Text] [Related]
2. [Advances in high-density whole genome-wide single nucleotide polymorphism array in cancer research].
Zeng ZY; Xiong W; Zhou YH; Li XL; Li GY
Ai Zheng; 2006 Nov; 25(11):1454-8. PubMed ID: 17094921
[TBL] [Abstract][Full Text] [Related]
3. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
4. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
Milne RL; Ribas G; González-Neira A; Fagerholm R; Salas A; González E; Dopazo J; Nevanlinna H; Robledo M; Benítez J
Cancer Res; 2006 Oct; 66(19):9420-7. PubMed ID: 17018596
[TBL] [Abstract][Full Text] [Related]
5. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
[TBL] [Abstract][Full Text] [Related]
6. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer.
Bernig T; Chanock SJ
Expert Rev Mol Diagn; 2006 May; 6(3):319-31. PubMed ID: 16706736
[TBL] [Abstract][Full Text] [Related]
7. Microarrays in breast cancer research and clinical practice--the future lies ahead.
Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
[TBL] [Abstract][Full Text] [Related]
8. The search for low-penetrance cancer susceptibility alleles.
Houlston RS; Peto J
Oncogene; 2004 Aug; 23(38):6471-6. PubMed ID: 15322517
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics and breast cancer: what can high-throughput genomic approaches actually tell us?
Sims AH
J Clin Pathol; 2009 Oct; 62(10):879-85. PubMed ID: 19174421
[TBL] [Abstract][Full Text] [Related]
10. Microarray-based DNA profiling to study genomic aberrations.
Waddell N
IUBMB Life; 2008 Jul; 60(7):437-40. PubMed ID: 18553550
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms and breast cancer: not yet a success story.
Tamimi RM
Breast Cancer Res; 2006; 8(4):108. PubMed ID: 16887007
[TBL] [Abstract][Full Text] [Related]
12. Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
Vega A; Salas A; Milne RL; Carracedo B; Ribas G; Ruibal A; de León AC; González-Hernández A; Benítez J; Carracedo A
Gynecol Oncol; 2009 Jan; 112(1):210-4. PubMed ID: 18950845
[TBL] [Abstract][Full Text] [Related]
13. The genetics and genomics of cancer.
Balmain A; Gray J; Ponder B
Nat Genet; 2003 Mar; 33 Suppl():238-44. PubMed ID: 12610533
[TBL] [Abstract][Full Text] [Related]
14. Primer: genomic and proteomic tools for the molecular dissection of disease.
Walker EJ; Siminovitch KA
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):580-9. PubMed ID: 17906613
[TBL] [Abstract][Full Text] [Related]
15. Whole-genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancer.
Liang X; Trentham-Dietz A; Titus-Ernstoff L; Newcomb PA; Welch RA; Hutchinson AA; Hampton JM; Sutcliffe CB; Haines JL; Egan KM
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1610-4. PubMed ID: 17684135
[TBL] [Abstract][Full Text] [Related]
16. From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome.
Monni O; Hyman E; Mousses S; Barlund M; Kallioniemi A; Kallioniemi OP
Semin Cancer Biol; 2001 Oct; 11(5):395-401. PubMed ID: 11562182
[TBL] [Abstract][Full Text] [Related]
17. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
19. Application of array-based genomic and epigenomic technologies to unraveling the heterogeneous nature of breast tumors: on the road to individualized treatment.
Abramovitz M; Leyland-Jones B
Cancer Genomics Proteomics; 2007; 4(3):135-45. PubMed ID: 17878517
[TBL] [Abstract][Full Text] [Related]
20. Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.
Grant SF; Hakonarson H
Expert Rev Mol Diagn; 2007 Jul; 7(4):371-93. PubMed ID: 17620046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
